Trials / Completed
CompletedNCT00885079
Confirmatory Study of OPC-12759 Ophthalmic Suspension
Confirmatory Study of OPC-12759 Ophthalmic Suspension in Dry Eye Patients
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 188 (actual)
- Sponsor
- Otsuka Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to verify whether OPC-12759 ophthalmic suspension is effective compared with active control in dry eye patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | OPC-12759 Ophthalmic suspension | OPC-12759 Ophthalmic suspension 2% |
| DRUG | Hyalein Mini Ophthalmic solution | Hyalein Mini Ophthalmic solution 0.1% |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2010-03-01
- Completion
- 2010-04-01
- First posted
- 2009-04-21
- Last updated
- 2013-12-12
- Results posted
- 2013-12-12
Locations
5 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00885079. Inclusion in this directory is not an endorsement.